[1] MURIEL P，ESCOBAR Y. Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride[J]. J Appl Toxicol，2003，23（2）:103-108.
[2] 郑敏，陈聪，赵雅萍，等. 探讨大鼠肝硬化动物模型的建立方法[J]. 肝胆外科杂志，2006，23（5）:136-137.
[3] 叶春华，刘浔阳. 四氯化碳综合法制备大鼠肝硬化模型[J]. 医学临床研究，2005，2（5）:619-622.
[4] SALGADO S，GARCIA J，VERA J，et al. Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy[J]. Mol Ther，2002，34（6）:545-551.
[5] GANG Z，QI Q，JING C，et al. Measuring microenvironment mechanical stress of rat liver during diethylnitrosamine induced hepatocarcinogenesis by atomic force microscope[J]. Microsc Res Tech，2009，72（9）:672-678.
[6] KANG JS，WANIBUCHI H，MORIMURA K，et al. Enhancement by estradiol 3-benzoate in thioacetamide-induced liver cirrhosis of rats[J]. Toxicol Sci，2005，85（1）:720-726.
[7] DE LA MHALL P，LIEBER CS，DECARLI LM，et al. Models of alcoholic liver disease in rodents:a critical evaluation[J]. Alcohol Clin Exp Res，2001，25（5）:254-261.
[8] KRESINA TF，HE Q，DEGLI ESPOSTI S，et al. Hepatic fibrosis and gene expression changes induced by praziquantel treatment during immune modulation of Schistosoma japonicum infection[J]. Parasitology，1993，107（4）:397-404.
[9] BARTLEY PB， RAMM GA，JONES MK，et al. A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis[J]. Int J Parasitol，2006，36（9）:993-1001.
[10] SINGH KP，GERARD HC，HUDSON AP，et al. Dynamics of collagen，MMP and TIMP gene expression during the granulomatous，fibrotic process induced by Schistosoma mansoni eggs[J]. Ann Trop Med Parasitol，2004，98（6）:581-593.
[11] ABDEL-AZIZ G，RESCAN PY，CLEMENT B，et al. Cellular sources of matrix proteins in experimentally induced cholestatic rat liver[J]. J Pathol，1991，164（2）:167-174.
[12] CHANG ML，YEH CT，CHANG PY，et al. Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation[J]. World J Gastroenterol，2005，11（27）:4167-4172.
[13] WAHL SM，HUNT DA，BANSAL G，et al. Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta[J]. J Exp Med，1988，168（4）:1403-1417.
[14] KOPP JB，FACTOR VM，MOZES M，et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease[J]. Lab Invest，1996，74（6）:991-1003.
[15] CLOUTHIER DE，COMERFORD SA，HAMMER RE. Hepatic fibrosis，glomerulosclerosis，and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice[J]. J Clin Invest，1997，100（11）:2697-2713.
[16] BREITKOPF K，ROEYEN C，SAWITZA I，et al. Expression patterns of PDGF-A，-B，-C and-D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells（HSC）[J]. Cytokine，2005，31（5）:349-357.
[17] BORKHAM-KAMPHORST E，STOLL D，GRESSNER AM，et al. Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis[J]. Biochem Biophys Res Commun，2004，321（2）:413-423.
[18] YOSHIJI H，KURIYAMA S，MIYAMOTO Y，et al. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model[J]. Hepatology，2000，32（6）:1248-1254.
[19] HENKEL C，RODERFELD M，WEISKIRCHEN R，et al. Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis[J]. Proteomics，2006，6（24）:6538-6548.
[20] LI X，BENJAMIN IS，ALEXANDER B. Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality[J]. J Hepatol，2002，36（4）:488-493.
[21] KREFT B，BLOCK W，DOMBROWSK I F，et al. Diagnostic value of a superparamagnetic iron oxide in MR imaging of chronic liver disease in an animal model[J]. AJR，1998，170（3）:661-668.
[22] DUNN MA，ROJKIND M，WARREN KS，et al. Liver collagen synthesis in murine schistosomiasis[J]. J Clin Invest，1977，59（4）:666-674.
[23] IRIE J，WU Y，WICKER LS，et al. NODc3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis[J]. J Exp Med，2006，203（5）:1209-1219.
[24] OERTELT S，LIAN ZX，CHENG CM，et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice[J]. J Immunol，2006，177（3）:1655-1660.
[25] 李鸿立，田聆，魏于全，等. 刀豆素蛋白A诱导小鼠肝纤维化模型的建立[J]. 免疫学杂志，2004，20（5）:390-393.
[26] 吴江锋，肖和杰. 猪血清联合ConA建立Balb/c小鼠肝纤维化模型及评价[J]. 解剖学杂志，2009，32（4）:546-548.
[27] MORI T，OKANOUE T，SAWA Y，et al. Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis[J]. Hepatology，1993，17（5）:891-897.
[28] 张文斌，姜海平，张海伟，等. SiO2与超液化碘油联合诱导的小鼠肝脏纤维化模型[J]. 中国病理生理杂志，2008，24（3）:622-624.
[29] PIETRANGELO A，GUALDI R，CASALGRANDI G，et al. Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis[J]. Hepatology，1994，19（3）:714-721.
[30] 曾燕，赵建，冷志，等. 不同浓度四氯化碳复合法诱导家兔肝纤化模型的建立[J]. 第三军医大学学报，2009，31（8）:694-696.
[31] 丁亚楠，潘兴华，刘志锋，等. 构建四氯化碳诱导的家兔肝纤维化模型[J]. 中国组织工程研究与临床康复，2008，12（46）:9066-9070.
[32] 胡晓峰，刘斌，张敏，等. 家兔肝纤维化模型的建立及肝功能指标与肝纤维化的相关性[J]. 实用肝脏病杂志，2007，10（3）:152-154.
[33] BRANDO CG，FERREIRA HH，PIOVESANA H，et al.Development of an experimental model of liver cirrhosis in rabbits[J]. Clin Exp Pharmacol Physiol，2000，27（12）:987-990.
[34] MADDEN JW，GERTMAN P，PEACOCK EE JR.Dimethylnitrosamine-induced hepatic cirrhosis:a new canine model of an ancient human disease[J]. Surgery，1970，68（1）:260-267.
[35] MWANZA T，MIYAMOTO T，OKUMURA M，et al. Ultrasonography，biochemical and hematological profiles in liver disease caused by intravenous administration of dimethylnitrosamine in dogs[J]. Jpn J Vet Res，1997，45（3）:153-161.
[36] 曹罡，黎一鸣. 门脉置管四氯化碳注射法制备狗肝硬化模型[J]. 中华肝胆外科杂志，2001，7（4）:244-245.
[37] FEINMAN L，LIEBER CS. Hepatic collagen metabolism: effect of alcohol consumption in rats and baboons[J]. Science，1972，176（36）:795.
[38] LIEBER CS，DECARLI LM. Animal models of chronic ethanol toxicity[J]. Methods Enzymol，1994，233:585-594.
[39] LIEBER CS，LEO MA，CAO Q，et al. Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons[J]. J Clin Gastroenterol，2003，37（4）:336-339.
[40] KREMSDORF D，BREZILLON N. New animal models for hepatitis C viral infection and pathogenesis studies[J]. World J Gastroenterol，2007，13（17）:2427-2435. |
